Jeffrey D. Bradley

Radiation Oncology

3400 Civic Center Boulevard
Concourse Level
Philadelphia, PA 19104

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 226 publications

Induction and consolidation atezolizumab with stereotactic body radiation therapy versus radiation alone in high-risk, early-stage non-small-cell lung cancer (SWOG/NRG S1914): a multicentre, open-label, superiority, phase 3, randomised controlled trial.

Induction and consolidation atezolizumab with stereotactic body radiation therapy versus radiation alone in high-risk, early-stage non-small-cell lung cancer (SWOG/NRG S1914): a multicentre, open-label, superiority, phase 3, randomised controlled trial.

Journal: Lancet (London, England)

Published: June 27, 2026

Comprehensive Patient Reported Outcomes (PROs) from NRG Oncology/Alliance LU005: A Randomized Trial Of Chemoradiation +/- Atezolizumab In Limited-Stage Small Cell Lung Cancer.

Comprehensive Patient Reported Outcomes (PROs) from NRG Oncology/Alliance LU005: A Randomized Trial Of Chemoradiation +/- Atezolizumab In Limited-Stage Small Cell Lung Cancer.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: June 09, 2026

Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: A Randomized Clinical Trial.

Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: A Randomized Clinical Trial.

Journal: JAMA

Published: June 01, 2026

A Systems Approach to Radiation-Induced Cardiopulmonary Toxicity-A Narrative Literature Review Focusing on the Interdependence of the Heart and the Lung in Thoracic Radiotherapy.

A Systems Approach to Radiation-Induced Cardiopulmonary Toxicity-A Narrative Literature Review Focusing on the Interdependence of the Heart and the Lung in Thoracic Radiotherapy.

Journal: Cancers

Published: May 22, 2026

Proton Therapy Utilization Among Adult Cancer Patients.

Proton Therapy Utilization Among Adult Cancer Patients.

Journal: International journal of particle therapy

Published: May 14, 2026

SKYSCRAPER-03: A Phase III Study of Tiragolumab Plus Atezolizumab Versus Durvalumab in Locally Advanced, Unresectable, Stage III NSCLC After Platinum-Based Concurrent Chemoradiation.

SKYSCRAPER-03: A Phase III Study of Tiragolumab Plus Atezolizumab Versus Durvalumab in Locally Advanced, Unresectable, Stage III NSCLC After Platinum-Based Concurrent Chemoradiation.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: May 08, 2026

Caution Against Uncritical Adoption of Neoadjuvant Chemoimmunotherapy Followed by Definitive Radiotherapy in Stages II to III NSCLC: In Response to Adib et al.

Caution Against Uncritical Adoption of Neoadjuvant Chemoimmunotherapy Followed by Definitive Radiotherapy in Stages II to III NSCLC: In Response to Adib et al.

Journal: JTO clinical and research reports

Published: April 22, 2026

FAST-02: Results from the second in-human prospective evaluation of single-fraction proton FLASH for symptomatic thoracic bone metastases.

FAST-02: Results from the second in-human prospective evaluation of single-fraction proton FLASH for symptomatic thoracic bone metastases.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: March 11, 2026

Inconsistent definitions of local control for stereotactic body radiation therapy for early-stage lung cancer - A systematic review.

Inconsistent definitions of local control for stereotactic body radiation therapy for early-stage lung cancer - A systematic review.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: January 26, 2026

Hypofractionated Proton Reirradiation for Recurrent Glioblastoma: Clinical and Dosimetric Outcomes from a Large Single Institution Series.

Hypofractionated Proton Reirradiation for Recurrent Glioblastoma: Clinical and Dosimetric Outcomes from a Large Single Institution Series.

Journal: International journal of radiation oncology, biology, physics

Published: January 15, 2026

Hypofractionated Proton Reirradiation for Recurrent Glioblastoma: Clinical and Dosimetric Outcomes from a Large Single-Institution Series.

Hypofractionated Proton Reirradiation for Recurrent Glioblastoma: Clinical and Dosimetric Outcomes from a Large Single-Institution Series.

Journal: International journal of radiation oncology, biology, physics

Published: January 15, 2026

Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005.

Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 13, 2026

Showing 1-12 of 226

Last Updated: 09/26/2026